KDM6A and bladder transitional cell carcinoma: Genomic analyses of several tumors revealed that loss of UTX occurs in various cancers, including B-cell lymphoma, bladder urothelial carcinoma, head and neck squamous cell carcinoma, pancreatic adenocarcinoma, lung squamous cell carcinoma, and kidney renal papillary cell carcinoma (Table 1)88–93.